Protagonist Therapeutics Inc (PTGX) — Long-term Investment Intensity
Protagonist Therapeutics Inc (PTGX) has a Long-term Investment Intensity of 14.6% as of September 2025. Long-term investments of $102.70 Million represent 14.6% of total assets of $701.69 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Protagonist Therapeutics Inc (PTGX) asset resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Protagonist Therapeutics Inc Long-term Investment Intensity (2014–2024)
This chart shows how Protagonist Therapeutics Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2024. As of September 2025, the intensity stands at 14.6%, reflecting long-term investments of $102.70 Million against total assets of $701.69 Million USD. For the complete balance sheet picture, see balance sheet size of Protagonist Therapeutics Inc.
Annual Long-term Investment Intensity for Protagonist Therapeutics Inc (2014–2024)
The table below presents the year-by-year Long-term Investment Intensity for Protagonist Therapeutics Inc from 2014 to 2024, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Protagonist Therapeutics Inc (PTGX) total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 18.8% | $140.25 Million | $744.73 Million | ▲ +18.2 pp |
| 2020 | 0.6% | $2.00 Million | $324.47 Million | ▼ -6.4 pp |
| 2017 | 7.0% | $11.46 Million | $163.73 Million | ▼ -3.8 pp |
| 2016 | 10.8% | $10.15 Million | $93.99 Million | ▼ -57.6 pp |
| 2015 | 68.4% | $10.15 Million | $14.85 Million | ▼ -29.9 pp |
| 2014 | 98.3% | $10.15 Million | $10.33 Million | — |